US stops AstraZeneca vaccine production at Baltimore plant: Report – Times of India

The US authorities on Saturday stopped a Baltimore manufacturing plant that ruined 15 million doses of Johnson & Johnson’s Covid-19 vaccine from making the vaccine developed by AstraZeneca Plc, the New York Times reported.
J&J stated in an announcement that it was “assuming full responsibility regarding the manufacturing of drug substance for its Covid-19 vaccine at the Emergent BioSolutions Inc. Bayview facility.”
It didn’t specify if it’ll take over the plant. The firm didn’t reply to Reuters’ requests for remark for clarification.
The New York Times reported that AstraZeneca stated in an announcement it’ll work with President Joe Biden’s administration to seek out another web site. The drugmaker didn’t reply to a request for remark.
The transfer by the US Department of Health and Human Services’ will render the Emergent BioSolutions facility solely devoted to creating the Johnson & Johnson single-dose vaccine, and is supposed to keep away from future combine-ups, based on the newspaper report, which cites two senior federal well being official
The US authorities’s prime infectious illness physician instructed Reuters the nation might not want AstraZeneca’s vaccine, even when it wins approval.

You may also like

More in:World

Leave a reply

Your email address will not be published. Required fields are marked *